Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Oct;26(4):606–607. doi: 10.1128/aac.26.4.606

Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.

M B Bansal, S K Chuah, H Thadepalli
PMCID: PMC179977  PMID: 6517552

Abstract

Azlocillin was active against 90% of 154 strains of Bacteroides fragilis at a concentration of 64 micrograms/ml. Twenty-eight strains of B. fragilis with an azlocillin MIC of greater than or equal to 8 micrograms/ml were retested with a combination of azlocillin plus clavulanic acid. Of these strains, 71% showed a 4- to 32-fold decrease in the MIC of azlocillin plus clavulanic acid.

Full text

PDF
607

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arank A., Syed S. A., Kenney E. B., Freter R. Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure. Appl Microbiol. 1969 Apr;17(4):568–576. doi: 10.1128/am.17.4.568-576.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crosby M. A., Gump D. W. Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production. Antimicrob Agents Chemother. 1982 Sep;22(3):398–405. doi: 10.1128/aac.22.3.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fu K. P., Neu H. C. Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother. 1978 Jun;13(6):930–938. doi: 10.1128/aac.13.6.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. König H. B., Metzger K. G., Mürmann R. P., Offe H. A., Schacht P., Schröck W. Azlocillin-ein neues Penicillin gegen Pseudomonas aeruginosa und andere gramnegative Bakterien. Infection. 1977;5(3):170–182. doi: 10.1007/BF01639754. [DOI] [PubMed] [Google Scholar]
  5. Martinelli R., Lopes A. A., de Oliveira M. M., Rocha H. Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin. Antimicrob Agents Chemother. 1981 Dec;20(6):800–802. doi: 10.1128/aac.20.6.800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Roy I., Bach V., Thadepalli H. In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin. Antimicrob Agents Chemother. 1977 Feb;11(2):258–261. doi: 10.1128/aac.11.2.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Wise R. Clavulanic acid and susceptibility of Bacteroides fragilis to penicillin. Lancet. 1977 Jul 16;2(8029):145–145. doi: 10.1016/s0140-6736(77)90161-1. [DOI] [PubMed] [Google Scholar]
  8. Wise R., Gillett A. P., Andrews J. M., Bedford K. A. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins. Antimicrob Agents Chemother. 1978 Apr;13(4):559–565. doi: 10.1128/aac.13.4.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Wise R., Gillett A. P., Andrews J. M. The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid. J Antimicrob Chemother. 1979 May;5(3):301–306. doi: 10.1093/jac/5.3.301. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES